on 28 Apr 2020
Last Applicant/ Owned by
E-03803 ALCOY
ES
Serial Number
79267691 filed on 17th Jul 2019
Registration Number
6039440 registered on 28th Apr 2020
Correspondent Address
Vivian Ortiz-Ponce
Filing Basis
No Filing Basis
Disclaimer
"CAFFEINE"
Pharmaceuticals for endurance sports for treating and promoting recovery tendon and muscle injuries and disorder and sport related injuries containing caffeine; dietetic food and substances adapted for medical use, for endurance sports containing caffeine; food supplements for human beings, namely, dietary supplements in the form of capsules, liquid, gel, powder for endurance sports containing cafRead More
Pharmaceuticals for endurance sports for treating and promoting recovery tendon and muscle injuries and disorder and sport related injuries containing caffeine; dietetic food and substances adapted for medical use, for endurance sports containing caffeine; food supplements for human beings, namely, dietary supplements in the form of capsules, liquid, gel, powder for endurance sports containing caffeine; cachets for pharmaceutical purposes, namely, drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; diet capsules containing caffeine; pharmaceutical preparations containing caffeine boosting energy; caffeine preparations for stimulative use
No 79267691
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 26th Sep 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 07th Sep 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| 04th Sep 2020 | FINAL DISPOSITION PROCESSED |
| 28th Jul 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 28th Apr 2020 | REGISTERED-PRINCIPAL REGISTER |
| 14th Feb 2020 | NOTIFICATION PROCESSED BY IB |
| 11th Feb 2020 | PUBLISHED FOR OPPOSITION |
| 11th Feb 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 29th Jan 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 29th Jan 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
